CrossrefInfokarte
Can Week 4 PASI Response Serve as an Early Predictor of Apremilast Efficacy in Psoriasis? A Single-Centre Preliminary Study
Acta Dermato-Venereologica · 2025-09-16 · 105 · adv44624
DOI: 10.2340/actadv.v105.44624 ↗Abstract
Kein Abstract verfügbar.
EUVIMED